Zura Bio (ZURA) Earnings Analysis

Zura Bio (ZURA) next reports earnings on 2026-08-13, consensus EPS -0.2 USD. Last quarter (2026-03-19) it missed with EPS -0.49 USD vs -0.18 USD est (-172.2%). It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E -4.95.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ZURA next report earnings?

Next earnings date2026-08-13
Consensus EPS estimate-0.2 USD
Revenue estimaten/a

ZURA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-19-0.49 USD-0.18 USD-172.2%Miss
2025-11-13-0.21 USD-0.19 USD-10.5%Miss
2025-08-14-0.17 USD-0.19 USD+10.5%Beat
2025-05-08-0.19 USD-0.17 USD-11.8%Miss

Beat rate: 1/4 (25%) over reported quarters with consensus data.

ZURA valuation and analyst view

Trailing P/E-4.95
Trailing EPS-0.67215 USD
Price / book2.79
Dividend yield0.00%
Market cap0.35B
Analyst consensusBuy (7 buy / 1 hold / 0 sell)
Avg price target15 USD

Related research pages

Frequently asked questions

When is Zura Bio (ZURA)'s next earnings date?

Zura Bio is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.2 USD.

Did ZURA beat earnings last quarter?

In its 2026-03-19 report, ZURA posted EPS of -0.49 USD versus a -0.18 USD estimate — a miss of 172.2%.

What is ZURA's earnings track record?

Over the last 4 reported quarters with consensus data, ZURA beat estimates 1 times (25%).

What is ZURA's current P/E ratio and EPS?

ZURA trades at a trailing P/E of -4.95 on trailing EPS of -0.672154031031968 USD.

What do analysts rate ZURA?

Analyst consensus is "Buy" across 8 ratings (1 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 15 USD.